BSL
Basilea Pharmace
Stock
Stock
ISIN: CH0011432447
Ticker: BSLN
CH0011432447
BSLN
Price
Price
CHART BY
Frequently asked questions
What is Basilea Pharmace's market capitalization?
The market capitalization of Basilea Pharmace is 501.21M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is the Earnings Per Share (EPS) for Basilea Pharmace?
Basilea Pharmace's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$0.0663. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Basilea Pharmace's stock?
Currently, 4 analysts cover Basilea Pharmace's stock, with a consensus target price of 68.63. Analyst ratings provide insights into the stock's expected performance.
What is Basilea Pharmace's revenue over the trailing twelve months?
Over the trailing twelve months, Basilea Pharmace reported a revenue of 149.02M.
What is the EBITDA for Basilea Pharmace?
Basilea Pharmace's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -4.99M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Basilea Pharmace?
Basilea Pharmace has a free cash flow of 9.34M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Basilea Pharmace have, and what sector and industry does it belong to?
Basilea Pharmace employs approximately 147 people. It operates in the Health Care sector, specifically within the Pharmaceuticals: Major industry.
What is the free float of Basilea Pharmace's shares?
The free float of Basilea Pharmace is 11.12M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- 501.21M
- EPS (TTM)
- -$0.0663
- Free Float
- 11.12M
- Revenue (TTM)
- 149.02M
- EBITDA (TTM)
- -4.99M
- Free Cashflow (TTM)
- 9.34M
Pricing
- 1D span
- $45.44$46.57
- 52W span
- $36.67$56.84
Analyst Ratings
The price target is 68.63 and the stock is covered by 4 analysts.
Buy
3
Hold
1
Sell
0
Information
Basilea Pharmaceutica AG engages in the development and commercialization of pharmaceutical products. Its products include antifungals and antibiotics. The company was founded on October 17, 2000, and is headquartered in Allschwil, Switzerland.
- Employees
- 147
- Industries
- Pharmaceuticals: Major
- Sector
- Health Care
Identifier
- ISIN
- CH0011432447
- Primary Ticker
- BSLN